MY135827A - Use of bradykinin-b2 receptor antagonists for treating osteoarthrosis - Google Patents

Use of bradykinin-b2 receptor antagonists for treating osteoarthrosis

Info

Publication number
MY135827A
MY135827A MYPI20040362A MYPI20040362A MY135827A MY 135827 A MY135827 A MY 135827A MY PI20040362 A MYPI20040362 A MY PI20040362A MY PI20040362 A MYPI20040362 A MY PI20040362A MY 135827 A MY135827 A MY 135827A
Authority
MY
Malaysia
Prior art keywords
bradykinin
diseases
receptor antagonists
joint
osteoarthrosis
Prior art date
Application number
MYPI20040362A
Inventor
Martin Dr Michaelis
Karl Dr Rudolphi
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of MY135827A publication Critical patent/MY135827A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/043—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

PEPTIDES HAVING BRADYKININ-ANTAGONISTIC ACTION ARE SUITABLE FOR THE PRODUCTION OF PHARMACEUTICALS FOR THE PROPHYLAXIS AND THERAPY OF DISEASES IN WHOSE COURCE AN INCREASED ACTIVITY OF MATRIX METALLOPROTEINASES IS INVOLVED. THESE INCLUDE DISEASES SUCH AS DEGENERATIVE JOINT DISEASES, FOR EXAMPLE OSTEOARTHROSIS, SPONDYLOSIS AND CHONDROPOROSIS AFTER JOINT TRAUMA OR RELATIVELY LONG IMMOBILIZATION OF A JOINT AFTER MENISCUS OR PATELLA INJURIES OR TORN LIGAMENTS.
MYPI20040362A 2003-02-07 2004-02-06 Use of bradykinin-b2 receptor antagonists for treating osteoarthrosis MY135827A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10304994A DE10304994A1 (en) 2003-02-07 2003-02-07 The use of antagonists of the bradykinin B2 receptor for the treatment of osteoarthrosis

Publications (1)

Publication Number Publication Date
MY135827A true MY135827A (en) 2008-07-31

Family

ID=32797325

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20040362A MY135827A (en) 2003-02-07 2004-02-06 Use of bradykinin-b2 receptor antagonists for treating osteoarthrosis

Country Status (31)

Country Link
EP (1) EP1594520B1 (en)
JP (1) JP2006516980A (en)
KR (1) KR20050105447A (en)
CN (1) CN1317029C (en)
AR (1) AR043036A1 (en)
AT (1) ATE335500T1 (en)
AU (1) AU2004210396A1 (en)
BR (1) BRPI0407333A (en)
CA (1) CA2514152C (en)
CO (1) CO5690613A2 (en)
CY (1) CY1105708T1 (en)
DE (2) DE10304994A1 (en)
DK (1) DK1594520T3 (en)
ES (1) ES2268622T3 (en)
HK (1) HK1085926A1 (en)
HR (1) HRP20050701B1 (en)
IL (1) IL169899A0 (en)
MA (1) MA27618A1 (en)
ME (1) MEP41008A (en)
MX (1) MXPA05007310A (en)
MY (1) MY135827A (en)
NO (1) NO333903B1 (en)
NZ (1) NZ541680A (en)
PE (1) PE20040939A1 (en)
PL (1) PL206412B1 (en)
PT (1) PT1594520E (en)
RS (1) RS51029B (en)
RU (1) RU2329057C2 (en)
TW (1) TW200505472A (en)
WO (1) WO2004069266A2 (en)
ZA (1) ZA200505177B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0710522D0 (en) * 2007-06-01 2007-07-11 Royal Veterinary College The Drug delivery system comprising matrix metalloproteinase inhibitors
IT1391236B1 (en) * 2008-07-11 2011-12-01 St Luso Farm D'italia Spa PHARMACEUTICAL COMPOSITIONS BASED ON ANTAGONISTS OF THE B2 KININE AND CORTICOSTEROID RECEPTOR AND THEIR USE

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE63490B1 (en) * 1988-11-24 1995-05-03 Hoechst Ag Peptides having bradykinin antagonist action
MX9100717A (en) * 1990-08-24 1992-04-01 Syntex Inc BRADIQUININE ANTAGONISTS
FR2751650B1 (en) * 1996-07-24 1998-10-09 Fournier Ind & Sante NOVEL N-BENZENESULFONYL-L-PROLINE COMPOUNDS, METHOD OF PREPARATION AND THERAPEUTIC USE
CA2364178C (en) * 2000-12-05 2006-01-10 Yasuhiro Katsu N-benzenesulfonyl l-proline compounds as bradykinin antagonists
CA2474645C (en) * 2002-02-01 2011-08-09 Omeros Corporation Compositions and methods for systemic inhibition of cartilage degradation

Also Published As

Publication number Publication date
TW200505472A (en) 2005-02-16
EP1594520A2 (en) 2005-11-16
DE10304994A1 (en) 2004-09-02
HRP20050701A2 (en) 2006-09-30
KR20050105447A (en) 2005-11-04
PL376605A1 (en) 2006-01-09
ATE335500T1 (en) 2006-09-15
HK1085926A1 (en) 2006-09-08
DK1594520T3 (en) 2006-12-11
DE502004001159D1 (en) 2006-09-21
MEP41008A (en) 2011-02-10
NZ541680A (en) 2009-07-31
JP2006516980A (en) 2006-07-13
IL169899A0 (en) 2011-08-01
MXPA05007310A (en) 2005-09-30
CO5690613A2 (en) 2006-10-31
CN1317029C (en) 2007-05-23
HRP20050701B1 (en) 2014-01-03
WO2004069266A3 (en) 2004-09-30
AR043036A1 (en) 2005-07-13
CA2514152C (en) 2012-01-17
NO333903B1 (en) 2013-10-14
ES2268622T3 (en) 2007-03-16
MA27618A1 (en) 2005-11-01
RS51029B (en) 2010-10-31
PT1594520E (en) 2006-11-30
ZA200505177B (en) 2006-11-29
RU2329057C2 (en) 2008-07-20
AU2004210396A1 (en) 2004-08-19
CY1105708T1 (en) 2010-12-22
NO20054144L (en) 2005-09-06
CN1747742A (en) 2006-03-15
PE20040939A1 (en) 2005-01-17
RU2005127862A (en) 2006-01-27
EP1594520B1 (en) 2006-08-09
CA2514152A1 (en) 2004-08-19
WO2004069266A2 (en) 2004-08-19
PL206412B1 (en) 2010-08-31
RS20050565A (en) 2007-09-21
BRPI0407333A (en) 2006-01-10

Similar Documents

Publication Publication Date Title
TR200201094T2 (en) Bicyclic amino acids as pharmaceuticals
AP1818A (en) Urea-compounds active as vanilloid receptor antagonists for the treatment of pain
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
MX2007008614A (en) Peptides with neuropeptide-2 receptor (y2r) agonist activity.
WO2005113537A3 (en) Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
GEP20074197B (en) 5ht2c receptor modulators
BR0309969A (en) Use of compounds that are effective as selective opioid receptor modulators
BRPI0307351B8 (en) compound, pharmaceutical composition, use of a compound, and, process for preparing a compound
PA8493701A1 (en) COMPOUNDS TO TREAT OBESITY
BRPI0512974A (en) New Hydantoin Derivatives for the Treatment of Obstructive Airway Diseases
AU2002344951A1 (en) Substituted piperazine and diazepanes as histamine h3 receptor agonists
MY137053A (en) Pyrimidine derivatives and their use as cb2 modulators
BRPI0411699A (en) compounds for use as a therapeutically active substance; method for the treatment and / or prophylaxis of diseases that are associated with cb1 receptor modulation and use of these compounds
ATE384058T1 (en) THIAZOLE DERIVATIVES
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
HUP0401915A2 (en) 4[piperidin-4-yliden-(3-carbamoylphenyl)methyl] benzamide derivatives and their use for the treatment of pain, spinal injuries or gastrointestinal disorders and pharmaceutical compositions containing them
AU2003255355A1 (en) Progesterone receptor modulators having an increased antigonadotropic activity for use in female fertility testing and hormone replacement therapy
MY135827A (en) Use of bradykinin-b2 receptor antagonists for treating osteoarthrosis
WO2004026837A3 (en) Histamine h3 receptor antagonists, preparaton and therapeutic uses
AU2003226765A1 (en) Azaindolylpiperidine derivatives as antihistaminic and antiallergic agents
UA95780C2 (en) Xanthine derivatives as selective hm74a agonists
IL153182A0 (en) Heterocyclic compounds, which are inhibitors of the enzyme dpp-iv
EE9900464A (en) Use of cartilage matrix oligomeric protein in the treatment of rheumatoid arthritis
MY139830A (en) Bicyclic imino acid derivatives as inhibitors of matrix metalloproteinases
EP1480678A4 (en) Treatment of ophthalmic disorders using urea and urea derivatives